ASX:CAUCronos Australia Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cronos Australia Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.10 0.00 (0.00 %) (As of 05/13/2020) Add Compare Share Today's RangeA$0.11Now: A$0.11▼A$0.1150-Day RangeA$0.08MA: A$0.09▼A$0.1152-Week RangeA$0.08Now: A$0.11▼A$0.42Volume23,416 shsAverage VolumeN/AMarket Capitalization$13.52 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Cronos Australia Limited operates as a medicinal cannabis company in Australia. It focuses on distributing tetrahydrocannabinol and cannabidiol products through brand development, outsourced manufacturing, and distribution agreements. The company was incorporated in 2018 and is based in Melbourne, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cronos Australia. Previous Next 2.5 Community Rank Outperform VotesCronos Australia has received 1 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCronos Australia has received 1 “underperform” votes. (Add your “underperform” vote.)Community SentimentCronos Australia has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cronos Australia and other stocks. Vote “Outperform” if you believe CAU will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CAU will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCronos Australia does not currently pay a dividend.Dividend GrowthCronos Australia does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cronos Australia insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$17,700.00 in company stock and sold A$0.00 in company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Australia is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Australia is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCronos Australia has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.23 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Drug Manufacturers—Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolASX:CAU Previous Symbol CUSIPN/A CIKN/A Webwww.cronosaustralia.com Phone1300 799 491Debt Debt-to-Equity Ratio11.43 Current Ratio51.19 Quick Ratio50.97Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$-18,718.00 Price / Sales-722.23 Cash FlowA$0.13 per share Price / Cash Flow0.79 Book ValueA$0.12 per share Price / Book0.88Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares128,750,000Market Cap$13.52 million Next Earnings DateN/A OptionableNot Optionable Receive CAU News and Ratings via Email Sign-up to receive the latest news and ratings for CAU and its competitors with MarketBeat's FREE daily newsletter. Cronos Australia (ASX:CAU) Frequently Asked Questions Has Cronos Australia been receiving favorable news coverage? News headlines about CAU stock have been trending somewhat negative on Sunday, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cronos Australia earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutCronos Australia. Who are some of Cronos Australia's key competitors? Some companies that are related to Cronos Australia include 48North Cannabis (NRTH), Willow Biosciences (WLLW), National Access Cannabis (META), Two Rivers Water & Farming (MJNE), Kali (RDGL), AAC Technologies (ABSCF), Abattis Bioceuticals (ATT), AgraFlora Organics International (AGRA), AgraFlora Organics International (AGFAF), Avicanna (PDDPF), Benitec Biopharma (BLT), Biome Grow (BIOIF), Body and Mind (BAMM), Chardan Healthcare Acquisition (PHGE) and Chemesis International (CSI). View all competitors. Who are Cronos Australia's key executives? Cronos Australia's management team includes the following people: Mr. Rodney Cocks, CEO & Exec. DirectorMr. Thomas Godfrey Howitt, Chief Financial Officer (Age 56)Mr. Lior Harel, Gen. Counsel & Company Sec.Mr. Peter John Righetti, Exec. Director What is Cronos Australia's stock symbol? Cronos Australia trades on the ASX under the ticker symbol "CAU." What is Cronos Australia's stock price today? One share of CAU stock can currently be purchased for approximately A$0.11. How big of a company is Cronos Australia? Cronos Australia has a market capitalization of $13.52 million and generates $-18,718.00 in revenue each year. What is Cronos Australia's official website? The official website for Cronos Australia is www.cronosaustralia.com. How can I contact Cronos Australia? The company can be reached via phone at 1300 799 491. This page was last updated on 5/31/2020 by MarketBeat.com Staff
